Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.8 USD | +0.44% | +0.03% | +15.37% |
Financials (USD)
Sales 2024 * | 63.88B | Sales 2025 * | 68.19B | Capitalization | 317B |
---|---|---|---|---|---|
Net income 2024 * | 19.48B | Net income 2025 * | 21.78B | EV / Sales 2024 * | 5.27 x |
Net Debt 2024 * | 19.65B | Net Debt 2025 * | 7.53B | EV / Sales 2025 * | 4.76 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
14.1
x | Employees | 71,000 |
Yield 2024 * |
2.45% | Yield 2025 * |
2.58% | Free-Float | 70.75% |
Latest transcript on Merck & Co., Inc.
1 day | +0.44% | ||
1 week | +0.03% | ||
Current month | -4.68% | ||
1 month | +2.93% | ||
3 months | +5.80% | ||
6 months | +25.24% | ||
Current year | +15.37% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 14-03-31 |
Director of Finance/CFO | 55 | 89-12-31 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 07-11-26 |
Pamela Craig
BRD | Director/Board Member | 67 | 15-08-31 |
Inge Thulin
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.34% | 215 M€ | +13.63% | - | |
5.61% | 18 M€ | +1.40% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 125.8 | +0.44% | 8,403,503 |
24-04-18 | 125.2 | -0.11% | 5,992,700 |
24-04-17 | 125.4 | +0.25% | 6,122,908 |
24-04-16 | 125.1 | -0.90% | 5,587,332 |
24-04-15 | 126.2 | +0.36% | 6,241,069 |
Delayed Quote Nyse, April 19, 2024 at 04:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.37% | 317B | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B | |
-3.20% | 113B |
- Stock Market
- Equities
- MRK Stock